logo
Site Network

Menu

Source Legend
  • Human-provided

    Entered or confirmed by an authorized person.

  • Google

    Imported Google information.

  • Trial-derived

    Calculated or extracted directly from associated trial records.

  • AI-inferred

    A capability inferred from trial history.

  • AI-extracted

    An explicit statement extracted from an official source.

  • Public registry

    Information from a public registry.

  • Site record

    Information held in the site record.

Source: Site record. Medinova Super Speciality Hospital Pvt Ltd's Shatabdi Hospital

Verified
+918042755069
customercare@medinovahospital.org
Source: Site record.
https://www.medinovahospital.org

Basic Information

Site Overview

Source: Human-provided.

Medinova Super Speciality Hospital (also referenced as Medinova Shatabadi Hospital) is a multi-specialty healthcare institution established in 2005 in Nashik (Mumbai Naka), India, offering a wide range of medical and surgical treatments with a focus on combining advanced technology with compassionate care. The hospital provides comprehensive services across disciplines such as internal medicine, orthopedics and joint replacement, pediatrics, pulmonology, cardiology, dermatology and more, supported by modern diagnostic facilities, modular operation theatres and a skilled team of doctors. It aims to deliver quality healthcare at economical rates while ensuring personalized attention to patients, emergency care, and accessible treatment options.

Source: Trial-derived.
9Total Trials
Source: Trial-derived.
0Recruiting Trials
Source: Trial-derived.
1Active Trials
Source: Trial-derived.
8Completed Trials
Source: Trial-derived.
9Unique Conditions
Source: Trial-derived.
7Unique Sponsors

Affiliations

Conditions

Source: Trial-derived. Breast Cancer (1)Source: Trial-derived. Carcinoma, Hepatocellular (1)Source: Trial-derived. Head and Neck Neoplasms (1)Source: Trial-derived. Kidney Neoplasms (1)Source: Trial-derived. Metastatic Breast Cancer (1)Source: Trial-derived. Multiple Myeloma (1)Source: Trial-derived. Non-small Cell Lung Cancer (1)Source: Trial-derived. Thyroid Cancer (1)

Sponsors

Source: Trial-derived. Pfizer (3)Source: Trial-derived. Boehringer Ingelheim (1)Source: Trial-derived. Eisai Pharmaceuticals India Pvt. Ltd (1)Source: Trial-derived. Exelixis (1)Source: Trial-derived. Janssen Research & Development, LLC (1)Source: Trial-derived. Johnson & Johnson Private Limited (1)Source: Trial-derived. mAbxience Research S.L. (1)

Trial Phases

Historical Trial Phase Experience

Source: Human-provided. Phase I
Source: Human-provided. Phase II
Source: Human-provided. Phase III
Source: Human-provided. Phase IV

Research Team & Staffing

Research team size (total staff)

Source: Human-provided. 23

Principal investigators

Source: Human-provided. 15

Study coordinators

Source: Human-provided. 6

Laboratory & Biospecimens

Laboratory and biospecimen capabilities inferred from trial participation

Source: AI-inferred. Specimen packaging and shipment
Source: AI-inferred. Timed pharmacokinetic sampling and processing

Research Pharmacy & Investigational Product

Investigational-product capabilities inferred from trial participation

Source: AI-inferred. Hazardous / cytotoxic drug handling
Source: AI-inferred. Sterile preparation (laminar-flow hood / BSC or cleanroom)

Clinical Procedures

Clinical procedures inferred from trial participation

Source: AI-inferred. Intravenous infusion administration

Accessibility & Parking

Accessibility Features

Source: Google. Wheelchair accessible entrance
Source: Google. Wheelchair accessible parking lot
Source: Google. Wheelchair accessible seating